Thermo Fisher Scientific, already a big player in providing services to the biopharmaceutical industry, is adding to its technology capabilities with the $9 billion acquisition of clinical trial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The largest medical device maker ...
Thermo Fisher (NYSE:TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data management firm at around $10B, the Financial Times reported, citing people ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The largest medical device maker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback